Neurotrope Issues Statement On Eli Lilly's Solanezumab
Go back to Neurotrope Issues Statement On Eli Lilly's Solanezumab| Neurotrope, Inc. Common (NASDAQ: NTRP) | Delayed: 1.80 +0.02 (1.12%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.78 | 52 Week High | $0.80 | |||
| Open | $1.81 | 52 Week Low | $0.20 | |||
| Day High | $1.83 | P/E | N/A | |||
| Day Low | $1.73 | EPS | $0.00 | |||
| Volume | 11,787 | |||||
